Author | Ryan W. Jacobs, MD | OncLive

Author | Ryan W. Jacobs, MD

Articles

Dr. Jacobs on Treating Graft-Versus-Host-Disease With Ibrutinib in CLL

March 06, 2019

Video

Ryan W. Jacobs, MD, physician, Levine Cancer Institute, discusses the use of ibrutinib (Imbruvica) in treating chronic graft-versus-host disease in patients with chronic lymphocytic leukemia (CLL).

Dr. Jacobs Discusses the Frontline Treatment of CLL

May 15, 2018

Video

Ryan W. Jacobs, MD, physician, Levine Cancer Institute, discusses the frontline treatment of patients with chronic lymphocytic leukemia.

Dr. Jacobs on the Efficacy of Ibrutinib and Acalabrutinib in Patients With MCL

May 09, 2018

Video

Ryan W. Jacobs, MD, physician, Levine Cancer Institute, discusses the efficacy of ibrutinib (Imbruvica) and acalabrutinib (Calquence) in patients with mantle cell lymphoma (MCL).

Dr. Jacobs on the Use of Ibrutinib in High-Risk Patients With CLL

April 27, 2018

Video

Ryan W. Jacobs, MD, physician, Levine Cancer Institute, discusses the use of ibrutinib (Imbruvica) in high-risk patients with chronic lymphocytic leukemia (CLL).

x